Haloperidol

proopiomelanocortin ; Homo sapiens







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 22483037 Nicotine-induced changes of brain β-endorphin. 2012 Jun 1
2 19394958 Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia. 2009 Sep 1
3 11679057 Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: effects of acute stress and 5-HT(1A) receptor activation. 2001 Oct 1
4 8290669 Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children. 1993 2
5 8408451 Evidence for two differentially regulated populations of peripheral beta-endorphin-releasing cells in humans. 1993 Oct 3
6 1649212 Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease. 1991 Mar 3
7 2143059 Effect of psychoactive drugs on lymphocyte neuropeptides. 1990 2
8 2830550 Biphasic changes in anterior pituitary Met-enkephalin concentration following reserpine treatment. 1988 Feb 1
9 2839820 [Neuroendocrine regulation of immunogenesis in alcoholism]. 1988 Mar-Apr 1
10 2951610 Neurosecretion of human hypothalamic immunoreactive beta-endorphin: in vitro regulation by dopamine. 1987 Mar 2
11 3021110 The influence of neurotensin, naloxone, and haloperidol on elements of excessive grooming behavior induced by ACTH. 1986 Sep 3
12 3461440 Detection of proopiomelanocortin mRNA by in situ hybridization with an oligonucleotide probe. 1986 Aug 1
13 6270192 Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro. 1981 Oct 1
14 6276051 Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism. 1981 Nov 1
15 6252497 Dopaminergic mediation of beta-endorphin-induced prolactin secretion. 1980 Oct 1
16 232360 Involvement of dopaminergic receptors in action of corticotropin releasing factor (CRF) under in vitro conditions. 1979 3
17 172929 Neuroendocrine effects of haloperidol therapy in chronic schizophrenia. 1975 Oct 14 1